Determinants of return to HIV treatment after interruption on ART among HIV positive clients in Katakwi District, Uganda
William Okello, Saadick Mugerwa Ssentongo, Bonniface Oryokot, Baker Bakashaba, Ronald Opito, Bosco Opio, Christine Acio, Ibrahim Jahun, Ibrahim Jahun, Ibrahim Jahun

TL;DR
This study identifies factors influencing HIV patients' return to treatment in Uganda, highlighting the role of occupation, distance to clinics, and community support.
Contribution
The study provides new insights into specific local determinants of return to HIV treatment in Katakwi District, Uganda.
Findings
Clients without an occupation were less likely to return to HIV treatment.
Positive community beliefs and community support groups increased the likelihood of returning to care.
Living within 5 km of a facility was associated with lower return rates compared to those 5–10 km away.
Abstract
Returning to treatment following interruptions is crucial for achieving optimal HIV care outcomes. In Uganda, despite a 20% treatment interruption rate, only 58% of clients successfully resume treatment. Evidence on determinants of returning to treatment remains limited. This study aimed to identify determinants of return to HIV treatment after interruption in Katakwi District, Uganda. We conducted a cross-sectional study at three high-volume antiretroviral therapy (ART) clinics in Katakwi District. Data were collected using face-to-face interviews from study adult participants and analyzed using Poisson generalized estimating equations (GEE) with robust standard errors to identify factors independently associated with a return to care. The rate of return to care was 63.9%. Clients without an occupation were less likely to return (aRR = 0.80, 95% CI: 0.73–0.88, p < 0.001).…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV/AIDS drug development and treatment · Global Maternal and Child Health
